Abbott Laboratories (ABT)
NYSE: ABT · IEX Real-Time Price · USD
-1.43 (-1.35%)
At close: Jun 12, 2024, 4:00 PM
-0.01 (-0.01%)
Pre-market: Jun 13, 2024, 7:00 AM EDT

Abbott Laboratories Revenue

Abbott Laboratories had revenue of $40.33B in the twelve months ending March 31, 2024, down -2.84% year-over-year. Revenue in the quarter ending March 31, 2024 was $9.96B with 2.23% year-over-year growth. In the year 2023, Abbott Laboratories had annual revenue of $40.11B, a decrease of -8.12%.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
181.58B USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 202340.11B-3.54B-8.12%
Dec 31, 202243.65B578.00M1.34%
Dec 31, 202143.08B8.47B24.47%
Dec 31, 202034.61B2.70B8.48%
Dec 31, 201931.90B1.33B4.34%
Dec 31, 201830.58B3.19B11.64%
Dec 31, 201727.39B6.54B31.35%
Dec 31, 201620.85B448.00M2.20%
Dec 31, 201520.41B158.00M0.78%
Dec 31, 201420.25B590.00M3.00%
Dec 31, 201319.66B607.00M3.19%
Dec 31, 201219.05B-2.36B-11.01%
Dec 31, 201121.41B-13.76B-39.13%
Dec 31, 201035.17B4.40B14.31%
Dec 31, 200930.76B1.24B4.19%
Dec 31, 200829.53B3.61B13.94%
Dec 31, 200725.91B3.44B15.30%
Dec 31, 200622.48B138.51M0.62%
Dec 31, 200522.34B2.66B13.51%
Dec 31, 200419.68B2.40B13.89%
Dec 31, 200317.28B2.00B13.09%
Dec 31, 200215.28B-1.01B-6.18%
Dec 31, 200116.29B2.54B18.47%
Dec 31, 200013.75B568.29M4.31%
Dec 31, 199913.18B664.89M5.31%
Dec 31, 199812.51B623.45M5.24%
Dec 31, 199711.89B875.82M7.95%
Dec 31, 199611.01B1.00B10.00%
Dec 31, 199510.01B856.19M9.35%
Dec 31, 19949.16B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Pfizer 55.09B
AbbVie 54.40B
Novartis AG 49.92B
AstraZeneca 47.61B
Thermo Fisher 42.49B
Amgen 29.53B
Danaher 22.52B
Stryker 20.96B
Revenue Rankings